Rumana C S, Valadka A B
Department of Neurosurgery, Baylor College of Medicine, Houston, Texas 77030, USA.
Neurosurgery. 1998 May;42(5):1038-43. doi: 10.1097/00006123-199805000-00049.
Gangliogliomas are indolent tumors comprised of neoplastic glial and neuronal cells. Benign lesions tend to be associated with long survival unless the tumor degenerates to a histologically malignant form. This study reviews four cases of histologically proven benign ganglioglioma that later demonstrated malignant features within the glial component of the tumor. Features common to each case are analyzed, and similar cases from the literature are reviewed.
The records of 42 supratentorial gangliogliomas operated on at our institution since 1985 were reviewed. Special attention was paid to histological characteristics, use of adjuvant radiotherapy, time to tumor recurrence, and histology of the recurrent tumor.
Of the 42 cases of gangliogliomas, 29 were initially histologically benign. Of these 29, 14 received postoperative radiation therapy and 14 did not; it was unclear whether one patient received adjuvant radiotherapy, and this patient was excluded from further analysis. Four benign gangliogliomas exhibited malignant degeneration of the glial component. These four all occurred in patients who had undergone postoperative irradiation. The time to identified histological change within recurrent tumors averaged 65 months (range, 22-144 mo).
All of the benign gangliogliomas undergoing malignant change had postoperative radiation therapy as a common feature. This represents a potential correlation that requires further study.
神经节胶质瘤是由肿瘤性神经胶质细胞和神经元细胞组成的惰性肿瘤。良性病变往往与长期生存相关,除非肿瘤退化为组织学上的恶性形式。本研究回顾了4例经组织学证实为良性的神经节胶质瘤病例,这些病例后来在肿瘤的神经胶质成分中表现出恶性特征。分析了每个病例的共同特征,并回顾了文献中的类似病例。
回顾了自1985年以来在我们机构接受手术的42例幕上神经节胶质瘤的记录。特别关注组织学特征、辅助放疗的使用、肿瘤复发时间以及复发肿瘤的组织学。
在42例神经节胶质瘤病例中,29例最初组织学为良性。在这29例中,14例接受了术后放疗,14例未接受;不清楚1例患者是否接受了辅助放疗,该患者被排除在进一步分析之外。4例良性神经节胶质瘤出现神经胶质成分的恶性退变。这4例均发生在接受术后放疗的患者中。复发肿瘤中确定组织学变化的时间平均为65个月(范围22 - 144个月)。
所有发生恶性变化的良性神经节胶质瘤都有术后放疗这一共同特征。这代表了一种潜在的相关性,需要进一步研究。